Dissection of Level III Axillary Lymph Nodes in Breast Cancer

被引：7

作者：

Hu, Jiejie ^{[1
]}

Xia, Xianghou ^{[1
]}

Yang, Hongjian ^{[1
]}

Yu, Yang ^{[1
]}

机构：

[1] Univ Chinese Acad Sci, Breast Surg Dept, Canc Hosp,Inst Canc & Basic Med IBMC, Zhejiang Canc Hosp,Chinese Acad Sci, Hangzhou 310022, Zhejiang, Peoples R China

来源：

CANCER MANAGEMENT AND RESEARCH | 2021年 / 13卷

关键词：

breast cancer; axillary lymph node dissection; level III; NEOADJUVANT CHEMOTHERAPY; FOLLOW-UP; INVOLVEMENT; METASTASES; MASTECTOMY; RELEVANCE; CARCINOMA;

D O I：

10.2147/CMAR.S290345

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Axillary lymph node dissection is an indispensable step in modified radical mastectomy for breast cancer. It is the most reliable method and the golden standard to determine the status of axillary lymph nodes. It is also of great importance to evaluate the prognosis and develop treatment plans for breast cancer patients. Axillary lymph node dissection can be anatomically divided into levels I, II, and III. Level I and Level II axillary lymph dissection is the standard clinical treatment of axillary lymph nodes positive breast cancer, whereas level III axillary lymph node dissection has been controversial. Level III axillary lymph node metastasis is one of the important factors that can easily cause distant metastasis and recurrence. It is also an important index to estimate the prognosis of breast cancer patients. To facilitate the decision of whether or not to perform level III lymph node dissection, we reviewed the indications, complications, and surgical procedures of level III lymph node dissection.

引用

页码：2041 / 2046

页数：6

共 37 条

[1]

Abe O, 2005, LANCET, V366, P2087, DOI 10.1016/s0140-6736(05)66544-0

[2] The Role for Sentinel Lymph Node Dissection after Neoadjuvant Chemotherapy in Patients who Present with Node-Positive Breast Cancer [J].

Alvarado, Rosalinda ;

Yi, Min ;

Le-Petross, Huong ;

Gilcrease, Michael ;

Mittendorf, Elizabeth A. ;

Bedrosian, Isabelle ;

Hwang, Rosa F. ;

Caudle, Abigail S. ;

Babiera, Gildy V. ;

Akins, Jeri S. ;

Kuerer, Henry M. ;

Hunt, Kelly K. .

ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (10) :3177-3184

[3]

Barros ACSD, 2013, TUMORI J, V99, P500

[4]

Crivellari D, 2006, J CLIN ONCOL, V24, P337, DOI DOI 10.1200/JCO.2005.01.5784

[5] Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials [J].

Davies, C. ;

Godwin, J. ;

Gray, R. ;

Clarke, M. ;

Darby, S. ;

McGale, P. ;

Wang, Y. C. ;

Peto, R. ;

Pan, H. C. ;

Cutter, D. ;

Taylor, C. ;

Ingle, J. .

LANCET, 2011, 378 (9793) :771-784

[6] The Value of Level III Clearance in Patients With Axillary and Sentinel Node Positive Breast Cancer [J].

Dillon, Mary F. ;

Advani, Vriti ;

Masterson, Catherine ;

O'Loughlin, Christina ;

Quinn, Cecily M. ;

O'Higgins, Niall ;

Evoy, Denis ;

McDermott, Enda W. .

ANNALS OF SURGERY, 2009, 249 (05) :834-839

[7] Level III axillary lymph nodes involvement in node positive breast cancer received neoadjuvant chemotherapy [J].

Fan, Zhaoqing ;

Li, Jinfeng ;

Wang, Tianfeng ;

Xie, Yuntao ;

Fan, Tie ;

Lin, Benyao ;

Ouyang, Tao .

BREAST, 2013, 22 (06) :1161-1165

[8] Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation [J].

Fisher, B ;

Jeong, JH ;

Anderson, S ;

Bryant, J ;

Fisher, ER ;

Wolmark, N .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (08) :567-575

[9] Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node Metastasis A Randomized Clinical Trial [J].

Giuliano, Armando E. ;

Hunt, Kelly K. ;

Ballman, Karla V. ;

Beitsch, Peter D. ;

Whitworth, Pat W. ;

Blumencranz, Peter W. ;

Leitch, A. Marilyn ;

Saha, Sukamal ;

McCall, Linda M. ;

Morrow, Monica .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (06) :569-575

[10] NCCN Guidelines® Insights Breast Cancer, Version 1.2017 Featured Updates to the NCCN Guidelines [J].

Gradishar, William J. ;

Anderson, Benjamin O. ;

Balassanian, Ron ;

Blair, Sarah L. ;

Burstein, Harold J. ;

Cyr, Amy ;

Elias, Anthony D. ;

Farrar, William B. ;

Forero, Andres ;

Giordano, Sharon Hermes ;

Goetz, Matthew P. ;

Goldstein, Lori J. ;

Isakoff, Steven J. ;

Lyons, Janice ;

Marcom, P. Kelly ;

Mayer, Ingrid A. ;

McCormick, Beryl ;

Moran, Meena S. ;

O'Regan, Ruth M. ;

Patel, Sameer A. ;

Pierce, Lori J. ;

Reed, Elizabeth C. ;

Salerno, Kilian E. ;

Schwartzberg, Lee S. ;

Sitapati, Amy ;

Smith, Karen Lisa ;

Smith, Mary Lou ;

Soliman, Hatem ;

Somlo, George ;

Telli, Melinda ;

Ward, John H. ;

Shead, Dorothy A. ;

Kumar, Rashmi .

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2017, 15 (04) :433-+

← 1 2 3 4 →